SANDOZ GEFITINIB
Аналоги SANDOZ GEFITINIB
Знайдіть доступніші аналоги та дженерики для SANDOZ GEFITINIB.
Активний інгредієнт: GEFITINIB
Опис товару
About SANDOZ GEFITINIB
SANDOZ GEFITINIB is a prescription medication containing the active ingredient Gefitinib, a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with certain epidermal growth factor receptor (EGFR) mutations.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with certain epidermal growth factor receptor (EGFR) mutations
- Monotherapy for patients with locally advanced or metastatic NSCLC who have not received prior chemotherapy
- First-line treatment for patients with NSCLC with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations
Active Ingredient & Action
GEFITINIB works by inhibiting the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) tyrosine kinase, which is involved in the signaling pathway that promotes the growth and survival of cancer cells. By blocking this pathway, Gefitinib helps to slow or stop the growth of cancer cells.
Important Notes
It is essential to consult a healthcare professional before taking SANDOZ GEFITINIB. The medication may cause serious side effects, including interstitial lung disease, liver damage, and diarrhea. Patients should be closely monitored for signs of these conditions and report any concerns to their doctor promptly.
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.
